Alpha galactosidase: Completed Phase I/II enrollment

Protalix completed enrollment of 18 treatment-naïve patients in an open-label, dose-escalation,

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE